I Kedar

22 papers receiving 404 citations

Peers

I Kedar
Comparison fields: 5 of 75
  • Nephrology 42
  • Molecular Biology 213
  • Immunology 58
  • Rehabilitation 16
  • Equine 4
Replace Hongbo Zhao with:
Hongbo Zhao China
Margaret Hoper United Kingdom
Xiuge Wang China
Kamalakar C. Nerusu United States
Yang Mi China
Michal Kandel-Kfir Israel
Wenyou Zhang China
Rachel M. Knott United Kingdom
Irene Nowowiejski United States
Esther Melgarejo Spain
I Kedar relative to Hongbo Zhao China Hongbo Zhao's profile →
Citations per field
00.5×
Hongbo Zhao · 1×
Citations per year

Countries citing papers authored by I Kedar

Since Specialization
Citations

This map shows the geographic impact of I Kedar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Kedar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Kedar more than expected).

Fields of papers citing papers by I Kedar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Kedar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Kedar. The network helps show where I Kedar may publish in the future.

Co-authors

The 25 scholars most cited alongside I Kedar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I Kedar Line = papers co-authored together I Kedar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 199997
2 198246
3
Colchicine inhibition of casein-induced amyloidosis in mice.
197440
4
Phase I and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamine.
199038
5 200132
6 197727
7 198325
8 198324
9
Degradation of amyloid by a serum component and inhibition of degradation.
198221
10
Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration.
197921
11 200420
12 198518
13 199815
14
In vitro synthesis of "amyloid"fibrils from insulin, calcitonin and parathormone.
197614
15 19985
16
Stimulation of murine amyloidosis by a dializable product from pretreated donors.
19754
17
Dimethyl sulfoxide in experimental atherosclerosis of the rabbit.
19814
18
Ascorbic acid-induced regression of amyloidosis in experimental animals.
19854
19 19863
20 20082

About I Kedar

I Kedar is a scholar working on Molecular Biology, Oncology, Immunology, Physiology and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 462 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Alzheimer's disease research and treatments (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Immunotherapy and Immune Responses (2 papers), Cell Adhesion Molecules Research (2 papers), Vitamin C and Antioxidants Research (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Nephrology (42 citations), Molecular Biology (213 citations), Immunology (58 citations), Rehabilitation (16 citations) and Equine (4 citations). I Kedar has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include M Ravid, E Sohar, Mordchai Ravid, J. Shapira, Jacob Gopas, Avi Golan‐Goldhirsh, P. Sathiyamoorthy, Yaakov Pollack, R Lang and J Gafni. Their work appears in journals such as Annals of the New York Academy of Sciences, Gynecologic Oncology, Journal of the American Geriatrics Society, Pharmaceutical Biology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact